GAS6 and non-small cell lung carcinoma: They also investigated the correlation between GAS6 mRNA levels and clinicopathological variables in patients with NSCLC, and found that increased GAS6 levels were positively associated with lymph node metastasis and advanced tumour-node-metastasis (TNM) stage, and predicted a poor prognosis, suggesting that the function of GAS6-AS1 might be mediated by GAS6.